Vitalhub (TSE:VHI) Sets New 12-Month Low Following Analyst Downgrade

Shares of Vitalhub Corp. (TSE:VHI – Get Free Report) hit a new 52-week low during mid-day trading on Tuesday after Royal Bank Of Canada downgraded the stock from a moderate buy rating to a hold rating. The company traded as low as C$6.46 and last traded at C$6.69, with a volume of 133,484 shares. The stock had previously closed at C$6.62.

Several other research analysts have also recently weighed in on VHI. Canaccord Genuity Group dropped their price objective on shares of Vitalhub from C$15.00 to C$14.50 and set a “buy” rating for the company in a research report on Monday. Raymond James Financial decreased their price objective on Vitalhub from C$11.00 to C$10.50 and set an “outperform” rating on the stock in a research report on Monday. ATB Cormark Capital Markets lowered their target price on Vitalhub from C$12.00 to C$10.25 and set an “outperform” rating for the company in a research note on Monday. Scotia dropped their target price on Vitalhub from C$12.00 to C$9.00 and set a “sector outperform” rating for the company in a research report on Monday. Finally, TD dropped their target price on Vitalhub from C$13.00 to C$9.50 and set a “buy” rating for the company in a research report on Monday. Eight equities research analysts have rated the stock with a Buy rating and one has given a Hold rating to the company. According to data from MarketBeat.com, the company has an average rating of “Moderate Buy” and an average target price of C$10.86.

Check Out Our Latest Research Report on Vitalhub

Trending Headlines about Vitalhub

Investors following VHI have been watching these headlines:

  • Positive Sentiment: Despite reducing their targets, Scotia, Stifel, TD, National Bank Financial, Raymond James, Canaccord Genuity and ATB Cormark maintained Buy, Outperform or Sector Outperform ratings. Their revised targets remain above the roughly C$6.62 reference price, suggesting analysts still see potential upside. Analyst rating updates
  • Neutral Sentiment: An article frames Vitalhub as integrating past acquisitions while preparing for further deals, a strategy that could support growth but also requires successful execution. Vitalhub: Digesting Acquisitions While Preparing For More
  • Negative Sentiment: Royal Bank of Canada downgraded Vitalhub from Moderate Buy to Hold (also reported as Sector Perform). In addition, seven firms cut their price targets—including Scotia to C$9.00, TD to C$9.50 and National Bank Financial to C$10.00—indicating a more cautious reassessment that may weigh on sentiment. Vitalhub Downgraded to Sector Perform at RBC

Vitalhub Trading Up 0.6%

The company has a market cap of C$421.84 million, a price-to-earnings ratio of 55.50, a P/E/G ratio of 1.18 and a beta of 1.37. The stock has a 50 day moving average price of C$7.53 and a two-hundred day moving average price of C$7.57.

Vitalhub (TSE:VHI – Get Free Report) last announced its quarterly earnings data on Thursday, November 12th. The company reported C$0.04 EPS for the quarter. The business had revenue of C$31.91 million during the quarter. Vitalhub had a return on equity of 4.03% and a net margin of 8.63%. On average, equities analysts forecast that Vitalhub Corp. will post 0.23 EPS for the current fiscal year.

Vitalhub Company Profile

(Get Free Report)

VitalHub is a leading software company dedicated to empowering health and human services providers globally. VitalHub’s comprehensive product suite includes electronic health records, operational intelligence, and workforce automation solutions that serve over 1,300 clients across the UK, Canada, and other geographies. The Company has a robust two-pronged growth strategy, targeting organic opportunities within its product suite and pursuing an aggressive M&A plan. VitalHub is headquartered in Toronto with over 700 employees globally, across key regions and the VitalHub Innovations Lab in Sri Lanka.

Further Reading

Receive News & Ratings for Vitalhub Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Vitalhub and related companies with MarketBeat.com's FREE daily email newsletter.